About tolebrutinib
Bruton tyrosine kinase inhibitor
Used for
- Investigated for multiple sclerosis; not an established approved treatment.
Usual adult dose
No established routine dose for approved use.
Common side effects
- Potential liver injury
- Infections
- Bleeding
Important warnings
- Approval and availability vary by country; this medicine may be investigational.
- Clinical studies have reported serious liver injury.
- Infection and bleeding risks require monitoring.
Pregnancy
Human pregnancy data are inadequate; potential fetal risk is uncertain.
Breastfeeding
Human data are inadequate; breastfeeding safety is unknown.
Interactions
- Other medicines that increase bleeding may raise bleeding risk.
- Medicines affecting liver enzymes may alter drug levels.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.